Header cover image

Semiconductors Healthcare Sector

Results

2312

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2,312 companies

Innoviva

Market Cap: US$1.2b

Engages in the development and commercialization of pharmaceutical products in the United States and internationally.

INVA

US$18.26

7D

-2.4%

1Y

13.3%

Pacira BioSciences

Market Cap: US$1.2b

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.

PCRX

US$23.40

7D

-7.0%

1Y

-24.1%

Sienna Senior Living

Market Cap: CA$1.6b

Provides senior living services in Canada.

SIA

CA$17.57

7D

3.1%

1Y

18.6%

Amphastar Pharmaceuticals

Market Cap: US$1.1b

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

AMPH

US$23.88

7D

0.04%

1Y

-42.2%

89bio

Market Cap: US$1.1b

A clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases.

ETNB

US$7.80

7D

1.7%

1Y

-15.2%

BioLife Solutions

Market Cap: US$1.1b

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

BLFS

US$23.09

7D

5.2%

1Y

2.9%

Pulse Biosciences

Market Cap: US$1.1b

Operates as a novel bioelectric medicine company.

PLSE

US$16.84

7D

1.8%

1Y

119.0%

Natus Medical

Market Cap: US$1.1b

Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide.

NTUS

US$32.96

7D

0.8%

1Y

34.4%

Aveanna Healthcare Holdings

Market Cap: US$1.1b

A diversified home care platform company, provides pediatric and adult healthcare services in the United States.

AVAH

US$5.86

7D

22.3%

1Y

128.0%

BGM Group

Market Cap: US$1.1b

Through its subsidiaries, operates as a pharmaceutical and chemical company in China.

BGM

US$11.58

7D

5.4%

1Y

n/a

NeoGenomics

Market Cap: US$1.1b

Operates a network of cancer-focused testing laboratories in the United States and the United Kingdom.

NEO

US$8.36

7D

8.7%

1Y

-45.7%

Evolent Health

Market Cap: US$1.1b

Through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.

EVH

US$9.27

7D

-10.4%

1Y

-61.1%

MiMedx Group

Market Cap: US$1.1b

Develops and distributes placental tissue allografts for various sectors of healthcare.

MDXG

US$7.17

7D

8.5%

1Y

-9.0%

Integra LifeSciences Holdings

Market Cap: US$1.1b

Manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.

IART

US$13.51

7D

6.0%

1Y

-48.9%

Aurinia Pharmaceuticals

Market Cap: US$1.1b

A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.

AUPH

US$7.82

7D

-3.6%

1Y

47.3%

Spire Healthcare Group

Market Cap: UK£786.2m

Owns and operates private hospitals and clinics in the United Kingdom.

SPI

UK£1.95

7D

-3.7%

1Y

-24.7%

Viridian Therapeutics

Market Cap: US$1.0b

Engages in discovering, developing, and commercializing treatments for serious and rare diseases.

VRDN

US$12.81

7D

6.5%

1Y

-12.7%

Novavax

Market Cap: US$1.0b

A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.

NVAX

US$6.19

7D

2.0%

1Y

-54.1%

Nika Pharmaceuticals

Market Cap: US$1.0b

Engages in the development and distribution of various pharmaceutical products.

NIKA

US$1.00

7D

0%

1Y

42.9%

Pennant Group

Market Cap: US$1.0b

Provides healthcare services in the United States.

PNTG

US$29.17

7D

8.7%

1Y

31.3%

InMode

Market Cap: US$1.0b

Designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.

INMD

US$14.92

7D

4.3%

1Y

-19.7%

Wave Life Sciences

Market Cap: US$1.0b

A clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.

WVE

US$6.39

7D

-0.3%

1Y

9.4%

Gyre Therapeutics

Market Cap: US$1.0b

A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.

GYRE

US$11.50

7D

29.9%

1Y

-26.4%

STAAR Surgical

Market Cap: US$1.0b

Designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.

STAA

US$19.00

7D

1.9%

1Y

-56.5%

Establishment Labs Holdings

Market Cap: US$1.0b

A medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries.

ESTA

US$34.96

7D

5.9%

1Y

-40.6%

OPKO Health

Market Cap: US$999.2m

A healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally.

OPK

US$1.30

7D

1.6%

1Y

-0.4%

Neuren Pharmaceuticals

Market Cap: AU$1.5b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

NEU

AU$13.18

7D

4.4%

1Y

-38.2%

Phibro Animal Health

Market Cap: US$993.1m

Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally.

PAHC

US$24.60

7D

29.2%

1Y

35.1%

Mineralys Therapeutics

Market Cap: US$985.5m

A clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.

MLYS

US$15.19

7D

2.9%

1Y

16.2%

Harrow

Market Cap: US$978.4m

An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.

HROW

US$26.27

7D

8.9%

1Y

61.8%

Nanosonics

Market Cap: AU$1.5b

Operates as an infection prevention company globally.

NAN

AU$4.69

7D

-3.5%

1Y

61.7%

Collegium Pharmaceutical

Market Cap: US$957.8m

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

COLL

US$29.80

7D

10.2%

1Y

-10.5%

Syndax Pharmaceuticals

Market Cap: US$945.7m

A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.

SNDX

US$10.19

7D

-4.2%

1Y

-53.0%

Enliven Therapeutics

Market Cap: US$932.7m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer.

ELVN

US$20.03

7D

1.7%

1Y

-16.1%

Oculis Holding

Market Cap: US$931.8m

A clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally.

OCS

US$17.76

7D

-3.0%

1Y

46.1%

Arcus Biosciences

Market Cap: US$931.8m

A clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States.

RCUS

US$8.67

7D

6.8%

1Y

-49.3%

Page 9 of 65